National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, France.
The Alliance for International Medical Action (ALIMA), Niamey, Niger.
Front Public Health. 2024 Aug 14;12:1357891. doi: 10.3389/fpubh.2024.1357891. eCollection 2024.
In the treatment of acute malnutrition (AM), non-response is considered a treatment failure for not meeting recovery criteria within a therapeutic window of 12-16 weeks, but this category of children is misunderstood. As current research emphasizes ways to simplify and optimize treatment protocols, non-response emerges as a new issue to enhance program efficiency.
A prospective cohort study was conducted from 2019 to 2020 at two health centres in Mirriah, Niger among children aged 6-59 months with uncomplicated AM treated under the Optimising treatment for Acute MAlnutrition (OptiMA) protocol. Children who did not meet recovery criteria by 12 weeks (mid-upper arm circumference (MUAC) ≥125 mm without oedema for two consecutive weeks) were classified as non-responders. Non-responders received a home visit six-months post-discharge. Logistic regression was used to analyze factors associated with non-responders compared with children who recovered.
Of the 1,112 children enrolled, 909 recovered and 139 were non-responders, of which 127 (80.6%) had significant MUAC gain (mean: +9.6 mm, sd = 5.1) at discharge. Girls (adjusted hazard ratio (aHR) = 2.07, 95% CI 1.33-3.25), children <12 months of age (aHr = 4.23, 95% CI 2.02-9.67), those with a MUAC <115 mm (aHR = 11.1, 95% CI 7.23-17.4) or severe stunting (aHR = 2.5, 1.38-4.83) at admission and a negative or flat MUAC trajectory between admission and week 4 (aHR = 4.66, 95% CI 2.54-9.13) were more likely to be non-responders. The nutritional status of non-responders had generally improved 6 months after discharge, but only 40% had achieved MUAC ≥125 mm.
Non-responders are not a homogeneous group; while most children ultimately show significant nutritional improvement, rapid hospital referral is crucial for those not gaining MUAC early in treatment. As efforts to expand MUAC-based programming progress, adapting exit criterion and/or providing additional food supplementation with smaller daily ration for children with risk factors discussed here may help improve programme efficiency without adding to the cost of treatment.
在治疗急性营养不良(AM)时,如果在 12-16 周的治疗窗口期内未达到恢复标准,就被认为是无反应,属于治疗失败,但这类儿童被误解了。由于目前的研究强调简化和优化治疗方案的方法,无反应成为提高项目效率的一个新问题。
2019 年至 2020 年,在尼日尔米拉伊的两个卫生中心,对年龄在 6-59 个月、接受优化急性营养不良治疗方案(OptiMA)治疗的无并发症急性营养不良儿童进行了一项前瞻性队列研究。在 12 周时(连续两周无水肿且中臂围(MUAC)≥125mm)未达到恢复标准的儿童被归类为无反应者。无反应者在出院后 6 个月进行家访。采用逻辑回归分析与恢复儿童相比,与无反应者相关的因素。
在纳入的 1112 名儿童中,909 名儿童康复,139 名儿童无反应,其中 127 名(80.6%)在出院时 MUAC 明显增加(平均:+9.6mm,标准差=5.1)。女孩(调整后的危险比(aHR)=2.07,95%可信区间 1.33-3.25)、<12 个月龄的儿童(aHr=4.23,95%可信区间 2.02-9.67)、入院时 MUAC<115mm(aHR=11.1,95%可信区间 7.23-17.4)或严重发育迟缓(aHR=2.5,1.38-4.83)以及入院至第 4 周 MUAC 呈负或平坦轨迹(aHR=4.66,95%可信区间 2.54-9.13)的儿童更有可能无反应。无反应者的营养状况在出院后 6 个月内通常有所改善,但只有 40%的人 MUAC 达到≥125mm。
无反应者不是一个同质群体;虽然大多数儿童最终表现出明显的营养改善,但对于那些在治疗早期未增加 MUAC 的儿童,快速转诊至医院至关重要。随着基于 MUAC 的方案扩展的努力取得进展,适应退出标准和/或为有上述风险因素的儿童提供较小每日剂量的额外食物补充,可能有助于提高项目效率,而不会增加治疗成本。